Bioequivalence Study of Generic Fluorouracil 0.5% Cream and 0.5% Carac® and Placebo
This is a double-blind, randomized, placebo-controlled, three treatment parallel study in which normal, healthy men and women (age 45-85) with actinic keratosis will be treated on the face once daily for two weeks with 5-Fluorouracil Cream 0.5%, Spear Pharmaceuticals (Generic), Carac® Cream 0.5% (Brand), or Cream Vehicle (Placebo). Actinic keratoses will be counted at the baseline visit and at the visit four weeks following cessation of treatment.
Actinic Keratoses
DRUG: Brand Carac|DRUG: Generic 0.5% 5-fluorouracil cream|OTHER: Placebo cream
Percent of patients with clearing, August 28, 2010 to March 17, 2011|Clearing of actinic keratosis, 42 days
superiority to placebo, 42 days
Irritation, 14 days
actinic keratosis